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Abstract
Introduction: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by various
systemic symptoms and multiple organ damage. We clarify biological and functional abnormalities in SLE by
comparing the gene expression profiles of SLE patients with those of healthy individuals.
Methods: Gene expression profiles from the peripheral blood of 21 SLE patients and 45 healthy individuals were
obtained using a DNA microarray. Gene ontology analysis and network pathway analysis were performed on the
genes differentially expressed between SLE and healthy individuals.
Results: A total of 2,329 upregulated genes and 1,884 downregulated genes were differentially expressed. Gene
ontology analysis revealed that the upregulated genes were classified as response to biotic stimulus genes, which
mainly includes genes related to immune response. Abnormalities in other categories such as cell motility and
regulation of apoptosis were also revealed. Downregulated genes were mainly sorted into two gene categories,
sensory perception and response to radiation/light. The sensory perception genes included ATPase/ATPase
domain-containing genes, myosin-related genes, and two excision repair cross-complementing genes, which are
involved in DNA repair. Other genes in this group - including three crystallin genes, genes encoding the receptor
protein for melanocyte-stimulating hormone, and six mitochondrial-DNA encoded genes, which are involved in
ATP synthesis - were also categorized as response to radiation genes. Using network pathway analysis, IL-6,
transforming growth factor beta 1, TNF, and hepatocyte nuclear factor 4a were found to play central roles in the
networks of sensory perception-related molecules.
Conclusions: Functional abnormalities in ATP synthesis and DNA repair are implicated in peripheral blood cells
from SLE patients.
Introduction
Systemic lupus erythematosus (SLE) is a prototypical
autoimmune disease characterized by various clinical
manifestations, high titers of autoantibodies, and multi-
ple organ damage [1]. Multiple genetic and environmen-
tal factors are thought to influence the disease progress,
but details of the mechanisms of SLE clinical manifesta-
tions or the biological processes behind them remain
obscure. The role of environmental factors pathologi-
cally involved in SLE, especially regarding skin lesions
after sun exposure, has been reported [2]. In addition,
abnormalities in apoptosis, impaired clearance of dying
cells, hyper-reactive B cells and T cells in the immune
system, and many other SLE pathophysiologies have also
been investigated [3,4]. From an autoimmunologic view-
point, disruption of self-tolerance is implicated through
distortion in the cell-cell communications and cytokine
networks. Nevertheless, there are few reports compre-
hensively considering the environmental factors in com-
bination with aberrant biological or cellular functions in
SLE, which involve a substantial number of molecules.
DNA microarrays can be amenable to exhaustively
analyze the gene expressions of such multiple molecules.
Indeed, Bennett and colleagues have demonstrated using
a microarray that type I interferon and its related mole-
c u l e sa sw e l la sg r a n u l o p o i e s i s - r e l a t e dm o l e c u l e sp l a y
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any medium, provided the original work is properly cited.central roles in SLE [5]. We and other researchers, also
using microarray analysis, confirmed the interferon sig-
nature in peripheral blood cells from patients with SLE
[6-8], where IFNa,I F N b,a n dT N Fm a yi n t e r a c tw i t h
each other in regulating the immune response molecules
[8,9]. Despite these important findings in immune
response, because SLE is a systemic disease that influ-
ences multiple organs, it is also important to clarify
other biological or cellular functional abnormalities rele-
vant to SLE clinical manifestations other than immuno-
logical response abnormality. In the present study, we
attempt to identify such abnormalities using differen-
tially expressed genes exhaustively analyzed by DNA
microarray together with bioinformatics analysis.
Materials and methods
Patients and healthy individuals
Twenty-one patients (all women, median age 35 years,
r a n g e2 6t o7 2y e a r s )w i t hS L Ea c c o r d i n gt ot h ed i a g -
nostic criteria of the American College of Rheumatology
[10] and 45 healthy individuals (23 males, 22 females)
were enrolled in the present study after providing writ-
ten informed consent. The study was approved by the
Ethical Committee of Wakayama Medical University for
clinical studies on human subjects. Twenty SLE patients
were treated with prednisolone <20 mg/day, and the
remaining one patient at 20 mg/day. Three of these 21
patients were treated with cyclosporine, with azathiopr-
ine, or with methotrexate in combination with predniso-
lone, respectively.
The median disease activity of SLE patients based on
the SLE Disease Activity Index (SLEDAI) 2000 score
was 6 (range 2 to 24) [11]. One patient was in a very
active state (SLEDAI 2000 score >12), 17 patients were
in active states (SLEDAI 2000 score = 4 to 12), and the
remaining three patients were not active (SLEDAI 2000
score <4). The median of the assessment based on the
BILAG index was 3 (range 1 to 13) [12]. Meanwhile, the
median of total white blood cells from SLE patients was
6,150/mm
3 (range 2,900 to 12,230/mm
3). The median
for the total number of and the proportion of neutro-
phils was 4,928/mm
3 and 80.0%, respectively (range
1,601 to 9,674/mm
3 and 55.2 to 90.1%), while that for
lymphocytes was 919/mm
3 and 14.7%, respectively
(range 376 to 1517/mm
3 and 4.7 to 24.5%).
DNA microarray and data analysis
Peripheral blood was collected directly into PAXGene
®
tubes (Qiagen, Valencia, CA, USA). Total RNA was
extracted using the PAXGene Blood RNA kit
® (Qiagen)
with optimal on-column DNase digestion. Amino allyl
R N A( a R N A )w a ss y n t h e s i z e df r o m1μgt o t a lR N A
using the Amino Allyl MessageAmp™ aRNA kit
(Ambion, Austin, TX, USA). Five micrograms of aRNA
from each sample (21 SLE patients and 45 healthy indi-
viduals) and the equivalent quantity of reference aRNA
from a mixture of RNA extracted from peripheral blood
of 45 healthy individuals were subjected to Cy3 and Cy5
labeling, respectively. Both labeled aRNA samples were
mixed in equal amounts and hybridized with an oligo-
nucleotide-based DNA microarray, AceGene
® (Huma-
nOligoChip30K; DNA Chip Research, Yokohama,
Japan), which contained 30,000 human genes. The
microarrays were scanned using ScanArray Lite
® (Perki-
nElmer, Boston, MA, USA).
Signal values were calculated using DNASIS Array
®
(Hitachi Software Engineering, Tokyo, Japan) according
to the manufacturer’s instructions. The intensities of no-
probe spots were used as the background. The median
and standard deviation of background levels were calcu-
lated. Genes whose intensities were less than the median
plus two standard deviations of background level were
identified as null. The Cy3/Cy5 ratios of all spots on the
DNA microarray were normalized by the global ratio
median. Only gene expression data that were collected
from at least 80% of samples from each group were
selected for further analysis. Microarray data have been
deposited in the NCBI Gene Expression Omnibus
[GEO:GSE17755].
Gene ontology and network pathway analysis
Genes identified to be differentially expressed according
to microarray analysis between SLE patients and healthy
individuals were functionally categorized using Expres-
sion Analysis Systematic Explorer (EASE) version 2.0
bioinformatics software [13]. Interactions among the
molecules of which the genes were differentially
expressed in their respective gene categories were inves-
tigated using Ingenuity Pathway Analysis version 8.0
[14]. Networks generated by less than five uploaded
genes were excluded from the analysis.
Statistical analysis
The unpaired Mann-Whitney test was used to deter-
mine statistically significant differences in the mRNA
expression levels between the SLE and healthy groups.
Correlation was measured using Spearman’sr a n k
correlation. The criterion for statistical significance was
P < 0.05.
Results
Gene ontology analysis on the differentially expressed
genes compared between SLE patients and healthy
individuals
DNA microarray analysis revealed that 4,213 genes were
differentially expressed in peripheral blood cells from
patients with SLE compared with healthy individuals:
2,329 out of the 4,213 genes were upregulated, while the
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number of the differentially expressed genes appeared to
reflect the pathological complexity involving many
molecules of this systemic disease with various clinical
manifestations.
To identify any aberrant biological functions in the
peripheral blood cells of SLE patients, we performed
EASE analysis based on the Gene Ontology database,
which can classify a large list of genes into functionally
related gene groups and rank the importance of these
functional groups on the differentially expressed genes.
EASE analysis classifies the gene groups into three Gene
Ontology systems: biological process, cellular compo-
nent, and molecular function. EASE results for the
biological process system for upregulated and downre-
gulated genes are shown in Tables 1 and 2, respectively.
The EASE score, which is a modified Fisher exact test,
represents the probability that over-representation of a
certain gene category occurs by chance. Based on com-
mon genes, gene categories were further divided into
subsets. Each subset of the gene categories was then
ordered hierarchically based on the gene list. Identical
gene lists are listed as one gene category. The list para-
meter refers to the total number of upregulated/downre-
gulated genes annotated in the Gene Ontology system
(data not shown). There were in total 1,759 genes in the
list for 2,329 upregulated genes and 1,429 genes in the
list for 1,884 downregulated genes. List hits represent
the number of upregulated/downregulated genes that
b e l o n gt ot h er e s p e c t i v eg e n ec a t e g o r y .T h ep o p u l a t i o n
parameter reports all genes annotated in the Gene
Ontology system (data not shown). The total number of
genes in the population of the biological process system
was 13,802. Population hits show the number of genes
t h a tb e l o n gt ot h er e s p e c t i v eg e n ec a t e g o r yi nt h e
system.
EASE analysis of the upregulated genes identified four
major gene categories: response to external stimulus,
cell growth and/or maintenance, cell motility, and regu-
lation of apoptosis (Table 1). The top-three most-signifi-
cant categories based on the EASE score - which include
response to biotic stimulus, defense response, and
immune response - were grouped into the response to
external stimulus category and were arranged hierarchi-
cally. The gene category cell growth and/or maintenance
included ubiquitin-dependent protein catabolism genes.
Finally, 62 upregulated genes belonged to the category
cell motility, in which 22 of the genes related to inflam-
matory response or antigen presentation (data not
shown) while 42 upregulated genes were in the category
regulation of apoptosis.
On the other hand, EASE analysis of the downregu-
lated genes identified four major gene categories: sen-
sory perception, response to radiation, calcium ion
transport, and macromolecule biosynthesis (Table 2).
The sensory perception category included ATPase/
ATPase domain-containing genes and two excision
repair cross-complementing genes (ERCC2, ERCC5). Six
mitochondrial DNA (mtDNA)-encoded genes - includ-
ing ATP synthase 6 (ATP6), cytochrome c oxidase
(COX)1, COX3, cytochrome b (CYTB), NADH dehydro-
genase subunit (ND)1, and ND2 - three crystallin genes,
and genes encoding the receptor protein for melano-
cyte-stimulating hormone (melanocortin 1 receptor)
were grouped into both the sensory perception category
and the response to radiation category. Except for mela-
nocortin 1 receptor, the 36 genes in the response to
radiation category were also in the response to light
Table 1 Deviated GO Biological Process gene categories of upregulated genes in peripheral blood of SLE patients
Gene category List hits (n = 1,759) Population hits (n = 13,802) EASE score (<0.01)
Response to external stimulus 265 1,539 6.56 × 10
-8
Response to biotic stimulus 192 963 7.36 × 10
-11
Defense response 176 887 7.69 × 10
-10
Immune response 159 792 2.45 × 10
-9
Response to stress 147 872 2.39 × 10
-4
Response to pest/pathogen/parasite 97 501 2.09 × 10
-5
Response to wounding 59 303 8.83 × 10
-4
Inflammatory response 48 187 2.68 × 10
-6
Cell growth and/or maintenance 572 4,092 3.09 × 10
-3
Modification-dependent protein catabolism 28 123 2.99 × 10
-3
Ubiquitin-dependent protein catabolism 27 122 5.34 × 10
-3
Cell motility 62 342 3.78 × 10
-3
Regulation of apoptosis 42 214 4.60 × 10
-3
Induction of apoptosis by extracellular signals 11 35 9.91 × 10
-3
Deviated Gene Ontology database (GO) Biological Process gene categories of upregulated genes in peripheral blood of systemic lupus erythematosus (SLE)
patients compared with healthy individuals. EASE, Expression Analysis Systematic Explorer software, version 2.0.
Lee et al. Arthritis Research & Therapy 2011, 13:R63
http://arthritis-research.com/content/13/2/R63
Page 3 of 9category. These results suggested the possible existence
of abnormalities in the above categorized functions.
Upregulated genes in the category regulation of
apoptosis and their network pathway analysis
Here, we focus on the 42 upregulated genes in the cate-
gory regulation of apoptosis. In order to identify the
relationship among these molecules and the centered
molecules in the networks, a network-based analysis was
conducted on these molecules. Two networks were
represented by the 42 upregulated genes (Figure 1).
Twenty-five of the 42 genes created the first network
(Figure 1a) with the NF-B complex and caspase com-
plex at the center. Caspases, or cysteine-aspartic pro-
teases, are a family of cysteine proteases that play
essential roles in apoptosis, necrosis and inflammation.
Caspase (CASP)3, CASP4, CASP6, and CASP10 genes
are in this network. Also present in the first network are
the CASP8 and FADD-like apoptosis regulator genes,
the B-cell CLL/lymphoma 2 gene, and TNF superfamily-
related genes, all of which are involved in the caspase
cascade, and the optic atrophy1 (OPA1) gene. OPA1 is
a component of the mitochondrial network and is
involved in the positive regulation of anti-apoptosis.
Meanwhile, many transcription factors such as p38
mitogen-activated protein kinase, extracellular signal-
regulated kinase, Ap1, and Akt represent the center of
the second network (Figure 1b). Presenilin1, which
relates to mitochondrial dysfunction, is also depicted in
this network.
Downregulated genes in the category sensory perception
and their network pathway analysis
The downregulated genes categorized into sensory per-
ception included ATPase/ATPase domain-containing
genes, two ERCC genes (ERCC2 and ERCC5), as well as
six mtDNA-encoded genes. Using network pathway ana-
lysis on the 56 genes in sensory perception, four net-
works were constructed (Figure 2).
A cluster of crystallin genes, COX1, COX3, ND1, and
ND2 are represented in the first network, in which IL-6,
transforming growth factor beta 1, and TNF are at the
center (Figure 2a). The second network has extracellular
signal-regulated kinase, NF-B, and mitogen-activated
protein kinase at the center (Figure 2b). The calcium
ion plays central roles in the third network (Figure 2c),
while hepatocyte nuclear factor 4a is important in the
final network (Figure 2d). ERCC2, ERCC5, and CYTB
were also found in the last network. The results also
showed that, among the 56 downregulated molecules,
there are six molecules involved in the pathways of oxi-
dative phosphorylation (ATP6, COX1, COX3, CYTB,
ND1, and ND2), in which three are relevant to mito-
chondrial dysfunction.
Because the expressions of DNA repair and mtDNA-
encoded genes were found downregulated, the relevant
gene expression levels were further investigated. Besides
the molecules mentioned above (ERCC2, ERCC5, CYTB,
COX1, COX3, ND1, ND2, and ATP6), the expression
levels of X-ray repair cross-complementing 6, COX2,
and ATP8 were also decreased in patients with SLE
(Figures 3 and 4). Several ATPases and ATP synthases
such as ATP2B1, ATP2B2, ATP5D, ATP5S, ATP6V1H,
ATP8A2, and ATP10B were also significantly downregu-
lated (unpaired Mann-Whitney test, P < 0.01) (data not
shown).
On the other hand, among the 21 SLE patients eight
had a history for manifestations of photosensitivity.
Among the 11 molecules identified in Figures 3 and 4,
only X-ray repair cross-complementing 6 expressions
correlated with the SLEDAI from the eight patients.
Meanwhile, we found only ND1 and ND2 expressions
correlated with the SLEDAI of all 21 SLE patients (data
not shown). These results may in part be due to the
small range of gene expression-level data gathered from
the AceGene
® microarray and the small variability in
SLEDAI of the patients recruited in the present study.
Discussion
In the present study, we compared the gene expression
profiles of 21 SLE patients (all females) with those of 45
healthy controls consisting of 23 males and 22 females.
Table 2 Deviated GO Biological Process gene categories of downregulated genes in peripheral blood of SLE patients
Gene category List hits (n = 1,429) Population hits (n = 13,802) EASE score (<0.01)
Sensory perception 56 383 7.49 × 10
-3
Perception of sound 21 82 2.00 × 10
-4
Hearing 20 81 4.86 × 10
-4
Response to radiation 36 222 7.48 × 10
-3
Response to light 35 207 4.39 × 10
-3
Calcium ion transport 16 66 2.57 × 10
-3
Macromolecule biosynthesis 131 1,002 3.38 × 10
-3
Protein biosynthesis 90 650 3.38 × 10
-3
Deviated Gene Ontology database (GO) Biological Process gene categories of downregulated genes in peripheral blood of systemic lupus erythematosus (SLE)
patients compared with healthy individuals. EASE, Expression Analysis Systematic Explorer software, version 2.0.
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comparison to the gene expression profiles of the 21
SLE patients with the 22 female controls only, finding
no changes to our conclusions. We include the 23 males
so that we can use the same control group for later stu-
dies when comparing other disease controls.
We and other researchers have reported that NF-B
signaling pathways play significant roles in the aberrant
immunoregulatory networks of SLE and other autoim-
mune disorders [8,15,16]. NF-Bi sak e yt r a n s c r i p t i o n
factor that regulates the expression of a wide range of
genes, including those involved in immune response,
cell adhesion, differentiation, proliferation, and apopto-
sis. Notably, Oikonomidou and colleagues demonstrated
that impaired NF-B signaling observed in SLE patients
can be partially explained by a decrease in NF-B
binding to DNA [17]. In the present study, we found
aberrant expression of the genes relevant to the cate-
gories regulation of apoptosis and response to light.
Since the NF-B complex was depicted in the center of
these genes by network pathway analysis, NF-Bh a s
again been thought to play a pathological role in regu-
lating apoptosis and response to light.
ERCC2, also called xeroderma pigmentosum comple-
mentation group D (XPD), encodes a protein involved
in transcription-coupled nucleotide excision repair.
Defects in the ERCC2 gene can result in three different
disorders: the cancer-prone XPD syndrome, trichothio-
dystrophy, and aging disorders Cockayne syndrome,
which is characterized by severe growth defects, mental
retardation, and cachexia [18,19]. ERCC2 is also a part
of human transcriptional initiation factor TFIIH and has
Figure 1 Network pathway analysis of upregulated genes in the gene category regulation of apoptosis. (a) Network 1 and (b) Network
2 constructed by 42 upregulated genes. (c) Network graphical representation. Genes or gene products are represented as individual nodes
whose shapes represent the functional class of the gene products. The biological relationship between the two nodes is represented as an edge
(line). All edges are supported by at least one reference from the literature stored in the Ingenuity Pathways Knowledge Base (IPKB). Genes with
colored nodes were found over-represented in the gene category regulation of apoptosis. Genes with uncolored nodes were not found over-
represented, but were depicted by computationally generated networks on the basis of evidence stored in the IPKB, indicating strong biologic
relevance to that network.
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xeroderma pigmentosum complementation group G
(XPG), also encodes a DNA repair protein. ERCC5 is
involved in excision repair of UV-induced DNA damage.
Mutations of this gene cause XPG syndrome or Cock-
ayne syndrome. Worth noting is the fact that the
ERCC2/XPD and ERCC5/XPG proteins are both
involved in excision repair of UV-induced DNA damage
and that photosensitivity is commonly observed in
patients with xeroderma pigmentosum, Cockayne syn-
drome, and trichothiodystrophy.
Since enhanced photosensitivity is also a common
clinical symptom for SLE, an abnormal expression of
ERCC2/XPD and ERCC5/XPG may be pathologically
involved in photosensitivity of SLE. An analysis of
ERCC2/XPD polymorphisms in patients with SLE
showed that these had no association with genetic sus-
ceptibility in SLE [20]. Bassi and colleagues, however,
reported that SLE leucocytes less efficiently repair radia-
tion-induced DNA damage and that DNA repair gene
polymorphic sites may predispose to the development of
particular clinical and laboratory features such as neu-
ropsychiatric manifestations and antiphospholipid anti-
body syndrome, although a significant association was
not observed in SLE patients [21]. Here we found ERCC
genes in the peripheral blood cells of SLE patients to be
underexpressed. It is important to confirm the gene
expression levels of DNA repair genes in skin, as skin is
Figure 2 Network pathway analysis of downregulated genes in the gene category sensory perception. (a) Network 1, (b) Network 2, (c)
Network 3, and (d) Network 4 constructed by 56 downregulated genes.
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(b) ERCC5, and (c) X-ray repair cross-complementing (XRCC)6 in peripheral blood of 21 patients with systemic lupus erythematosus (SLE) and 45
healthy individuals (HI) are shown. All data represent microarray data with the expression values of log2(sample/reference). *P < 0.05, **P < 0.01,
***P < 0.001 (unpaired Mann-Whitney test) for 21 SLE patients versus 45 HI. Boxes contain the 50% of values falling between the 25th and 75th
percentiles, the horizontal line within the box represents the median value, and the whiskers are the lines that extended from the box to the
highest and lowest values, excluding outliers.
Figure 4 Decrease in the expressions of nine mitochondrial DNA-encoded genes. The expression levels of (a) cytochrome c oxidase (COX)
1, (b) COX2, (c) COX3, (d) cytochrome b (CYTB), (e) NADH dehydrogenase subunit (ND)1, (f) ND2, (g) ATP synthase (ATP)6, and (h) ATP8 in
peripheral blood of 21 patients with systemic lupus erythematosus (SLE) and 45 healthy individuals (HI) are shown. All data represent microarray
data with the expression values of log2(sample/reference). *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired Mann-Whitney test) for 21 SLE patients
versus 45 HI. Boxes contain the 50% of values falling between the 25th and 75th percentiles, the horizontal line within the box represents the
median value, and the whiskers are the lines that extended from the box to the highest and lowest values, excluding outliers.
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with the environment, as is the case for sun exposure.
Although the detailed biological characteristics of photo-
sensitivity are still unknown, it is possible that UV light
induces the accumulation of damaged DNA due to
decrease in ERCC expression. As a result, abnormal
apoptosis can occur, which results in poor disposal of
cell debris including DNA. This in turn can lead to an
overexpression of interferons by antigen-presenting
cells, including plasmacytoid dendritic cells, which ulti-
mately can lead to SLE systemic symptoms. ERCCs are
also involved in the transcription-coupled repair of oxi-
dative DNA lesions. A decrease in ERCC expression
may thus contribute the susceptibility to oxidative stress
in SLE.
Abnormalities in the mitochondria have been a topic
of interest for SLE studies for several years [22]. It has
been reported that lupus T cells exhibit mitochondrial
hyperpolarization, resulting in ATP depletion, and thus
contribute to abnormal T-cell activation and cell death
in patients with SLE [23]. We report that certain gene
groups related to the function of sensory perception are
underexpressed in the peripheral blood cells of SLE
patients. Notably, of the relevant genes, six are mtDNA-
encoded genes (ATP6, COX1, COX3, CYTB, ND1, and
ND2) that also function in oxidative phosphorylation,
where defects in three of them (COX1, COX3, and
CYTB) also lead to mitochondrial dysfunction.
Also worth noting is that repairs of UV-induced DNA
damage by ERCC2/XPD and ERCC5/XPG requires
ATP. The ATP and DNA binding regions are contained
in ERCC2/XPD [24]. Most amino-acid substitution var-
iants of ERCC2/XPD found in patients with xeroderma
pigmentosum, Cockayne syndrome, and trichothiody-
strophy occur in these regions. Although the reports
mentioned above found no genetic variations in ERCC2/
XPD or ERCC5/XPG when they were linked to SLE, the
observed mitochondrial dysfunction in SLE, which
implicates ATP depletion [20,21], combined with the
underexpression of ATP-dependent ERCC genes sug-
gests impaired DNA repair or consequently increased
apoptosis, both of which may contribute the clinical or
laboratory manifestations of SLE. Moreover, OPA1 and
nuclear respiratory factor 1 expressions were found to
increase (data not shown). OPA1 is necessary for the
synthesis of new mitochondrial components, while
nuclear respiratory factor 1 functions as a transcription
factor that activates the expression of certain nuclear
genes required for mtDNA transcription and replication
[25,26]. Perl’s group has added that persistent mitochon-
drial hyperpolarization is associated with increased
mitochondrial biogenesis in SLE T cells [27], although
the molecules above were not mentioned in their study.
The increase in OPA1 and nuclear respiratory factor 1
expressions may compensate for the mitochondrial dys-
function seen in SLE.
In our previous study in systemic juvenile idiopathic
arthritis, we showed abnormal downregulation of genes
related to oxidative phosphorylation, suggesting a mito-
chondrial disorder [28]. It is interesting that we also
identified downregulation of mtDNA-encoded genes
involved in oxidative phosphorylation in the present
study. Slight downregulation of ERCC2 expression was
also observed in systemic juvenile idiopathic arthritis.
We did not, however, identify other abnormal expres-
sions of ERCC genes or oxidative phosphorylation-
related genes in rheumatoid arthritis or polyarticular
type juvenile idiopathic arthritis, although a downregula-
tion of the gene expressions for ATP6 and CYTB were
found in rheumatoid arthritis (unpublished data).
Moreover, it is interesting that proinflammatory cyto-
k i n e ss u c ha sI L - 6a n dT N F ,as well as anti-inflamma-
tory cytokines including transforming growth factor
beta, were found to play central roles in the networks of
sensory perception molecules, which included oxidative
phosphorylation-related molecules. The roles of cyto-
kines in the immunoregulatory network of autoimmune
diseases as well as the relationship of mitochondria with
apoptosis have been previously reported, while few stu-
dies have described the relationships between cytokines
and mitochondria [29-33]. These reports suggested that
we cannot eliminate the possibility that chronic inflam-
mation with imbalanced cytokine homeostasis may alter
mitochondrial function.
Conclusions
Functional abnormalities of ATP synthesis and DNA
repair were implicated in peripheral blood cells from
patients with SLE, but more investigation needs to be
conducted to further elucidate the mechanisms involved
in SLE.
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